Health care provider management of patients with type 2 diabetes mellitus: Analysis of trends in attitudes and practices

Postgraduate Medicine

Volumn 126, Issue 3, 2014, Pages 145-160

  Williamson, Chad ^a   Glauser, Terry Ann ^a   Burton, B Stephen ^a   Schneider, Doron ^b   Dubois, Anne Marie ^c   Patel, Daxa ^c  

^a CE Outcomes   (United States)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

^c NOVO NORDISK INC   (United States)

Author keywords

Case vignette; Diabetes mellitus; Practice gaps; Practice pattern; Survey

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INCRETIN; INSULIN; ISOPHANE INSULIN; LONG ACTING INSULIN; SULFONYLUREA; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; INSULIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DIABETES EDUCATOR; ENDOCRINOLOGIST; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERNIST; MALE; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; OBESITY; PHARMACIST; PHYSICIAN ASSISTANT; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; COMMUNICATION DISORDER; DISEASE MANAGEMENT; DRUG POTENTIATION; PATIENT REFERRAL; PRACTICE GUIDELINE; STATISTICS;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; COMMUNICATION BARRIERS; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DISEASE MANAGEMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INCRETINS; INSULINS; MALE; PRACTICE GUIDELINES AS TOPIC; RECEPTORS, GLUCAGON; REFERRAL AND CONSULTATION;

EID: 84906933353     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2014.05.2764     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. http://www. cdc.gov/diabetes/pubs/factsheet11.htm. Accessed September 12, 2013.
2. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;368(6):1613-1624.
3. Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement-executive summary. Endocr Pract. 2013;19(3):536-537.
4. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Associationn (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
5. Chou AF, Brown AF, Jensen RE, Shih S, Pawlson G, Scholle SH. Gender and racial disparities in the management of diabetes mellitus among Medicare patients. Womens Health Issues. 2007;17(3):150-161.
6. Choi S, Lee J-A, Rush E. Ethnic and language disparities in diabetes care among California residents. Ethn Dis. 2011;21(2):183-189.
7. Bulger JB, Shubrook JH, Snow R. Racial disparities in African Americans with diabetes: process and outcome mismatch. Am J Manag Care. 2012;18(8):407-413.
8. Chew LD, Schillinger D, Maynard C, Lessler DS; Consortium for Quality Improvement in Safety Net Hospitals. Glycemic and lipid control among patients with diabetes at six US public hospitals. J Health Care Poor Underserved. 2008;19(4):1060-1075.
9. Woodard LD, Urech T, Landrum CR, Wang D, Petersen LA. The impact of comorbidity type on measures of quality for diabetes care. Med Care. 2011;49(6):605-610.
10. Alexander CG, Sehgal N, Moloney RM, Stafford RS. National trends in the treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008;168(19):2088-2094.
11. Brouwer ES, West SL, Kluckman M, et al. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record. Pharmacoepidemiol Drug Saf. 2012;21(9):920-928.
12. Desai NR, Shrank WH, Fischer MA, et al. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med. 2012;125(3):302e1-302e7.
13. Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007;30(6):1448-1453.
14. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62(6):860-868.
15. Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educ. 2012;38(1):94-100.
16. Peyrot M, Rubin RR. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus. Curr Med Res Opin. 2008;24(8):2413-2422.
17. Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy; patient and health care provider perspectives. Diabetes Educ. 2009;35(6):1014-1022.
18. Beaser RS, Okeke E, Neighbours J, Brown J, Ronk K, Wolyniec WW. Coordinated primary and specialty care for type 2 diabetes mellitus, guidelines, and systems: an educational needs assessment. Endocr Pract. 2011;17(6):880-890.
19. Ritholz MD, Beverly EA, Abrahamson MJ, Brooks KM, Hultgren BA, Weinger K. Physicians' perceptions of the type 2 diabetes multidisciplinary treatment team: a qualitative study. Diabetes Educ. 2011;37(6):794-800.
20. McCraw WM, Kelley PW, Righero AM, Latimer R. Improving compliance with diabetes clinical practice guidelines in military medical treatment facilities. Nurs Res. 2010;59(1 Suppl):S66-S74.
21. Caruso LB, Cough-Gorr KM, Silliman RA. Improving quality of care for urban older people with diabetes mellitus and cardiovascular disease. J Am Geriatr Soc. 2007;55(10):1656-1662.
22. Guzek J, Guzek S, Murphy K, Gallacher P, Lesneski C. Improving diabetes care using a multitiered quality improvement model. Am J Med Qual. 2009;24(6):505-511.
23. Reichsman A, Werner J, Cella P, Bobiak S, Stange KC; SNPSA Diabetes Study Working Group. Opportunities for improved diabetes care among patients of safety net practices: a safety net providers' strategic alliance study. J Natl Med Assoc. 2009;101(1):4-11.
24. Williamson JC, Glauser TA, Nevins PH, et al. Current practice patterns and identified educational needs of health care providers in managing patients with type 2 diabetes. Clini Diabetes. 2014;3(2):90-95.
25. Delbecq AL, Van de Ven AH. A group process model for problem identification and program planning. J Appl Behav Sci. 1971;7(4):466-492.
26. Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141(10):771-780.
27. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283(13):1715-1722.
28. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
29. Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):S1-S53.
30. Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones: systemic review and meta-analysis of observational studies. BMJ. 2011;342:d1309.